These data support and expand on prior observations on the association with EGFR mutations, adenocarcinoma histologic components, and APOBEC mutagenesis in RB1−/TP53− nsSCLC (10, 42, 48, 49) and highlight the contrast between these cases and aSCLC. The gene discussed is EGFR; the disease is adenocarcinoma.